Search results for: Infectious Diseases
Filter search results
Just Published: Systematic Review of PRO Use in Paediatric Populations with Vaccine-Preventable Infectious Diseases
15 December 2015
This paper reports the results of a systematic review of the use and quality of Patient Reported Outcome (PRO) measures in paediatric populations with vaccine-preventable infectious diseases in developed countries….
Just Published: Systematic Review of Utility Weights Used in Economic Evaluations of Vaccines for Paediatric Infectious Diseases
21 April 2016
…recently been published in Value in Health, which reports a systematic review of the sources and characteristics of utility weights used to assess the cost-effectiveness of vaccines for infectious diseases…
New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options
1 April 2011
…infectious diseases, thereby increasing the probability of complications, morbidity and mortality. The World… Antimicrobial resistance (AMR) to drugs is a natural and unavoidable consequence of treating infectious diseases. A growing…
Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty
1 December 2002
…to treat and ultimately eradicate the infectious diseases prevalent predominately in the poorest regions of the developing world. This book focuses on the role of public-private partnerships (PPPs) as an…
OHE’s 50th Celebration: Publications on Tuberculosis Show Constancy and Change
23 August 2012
…40% from 1990 to 2010.[3] For TB and other deadly infectious diseases, encouraging treatment innovation is critical. Recent OHE research has focused on this important policy issue. [1] Health Protection…
Immunisation for Everyone – The Polio Experience
1 September 1979
…effective and safe immunising techniques. There are today around 80 vaccines which protect against a wide range of infectious diseases. The purpose of this OHE briefing is to highlight key…
New Antimicrobial Drugs: EU Policy Options
4 October 2010
…consequence of treating infectious diseases, is a growing global public health threat. AMR reduces the chances of successfully treating patients with infectious diseases, thereby increasing the probability of complications, morbidity…
Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
…Health Challenges The world is currently undergoing significant demographic shifts, with ageing populations as the dominant trend. For infectious diseases, such as shingles and pneumococcal disease, the incidence and severity…
New Drugs to Tackle Antimicrobial Resistance: EU Policy Options
1 October 2010
Antimicrobial resistance (AMR) to drugs, a natural and unavoidable consequence of treating infectious diseases, is a growing global public health threat. The EU Commission is to develop comprehensive proposals by…